Jennifer M. Tjon
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Long-term outcome of a DLI-based treatment strategy in patients with relapsed AML after TCD allogeneic stem cell transplantation is hampered by GvHD and late relapse.
Journal: Transplantation and cellular therapy
Published: June 02, 2026
Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity.
Journal: Bone marrow transplantation
Published: April 26, 2026
Selective lymphodepletion underlies the efficacy of horse anti-thymocyte globulin-based immunosuppressive therapy in aplastic anemia.
Journal: Haematologica
Published: October 03, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report.
Journal: Haematologica
Published: December 18, 2024
Quality of life after immune suppressive therapy in aplastic anemia.
Journal: Annals of hematology
Published: October 31, 2023
SARS-CoV-2 mRNA vaccination of aplastic anemia patients is safe and effective.
Journal: American journal of hematology
Published: July 26, 2022
Anti Thymocyte Globulin-Based Treatment for Acquired Bone Marrow Failure in Adults.
Journal: Cells
Published: August 31, 2021
Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?
Journal: Infectious disease reports
Published: June 22, 2021
Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.
Journal: British journal of haematology
Published: October 08, 2016
Last Updated: 09/26/2026